Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03996967 · ClinicalTrials.gov registry record
Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia
A clinical trial, sponsored by Boston University.
- Completed
- Registry status
- 837
- Enrollment target
NCT03996967 is a clinical trial that has completed, run by Boston University. The registered enrollment target is 837 participants.
The verdict
NCT03996967 has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- 837 participants
- Enrollment target
Study Summary
Clinical pneumonia is a leading cause of pediatric hospitalization. The etiology is generally bacterial or viral. Prompt and optimal treatment of pneumonia is critical to reduce mortality. However, adequate pneumonia management is hampered by: a) the lack of a diagnostic tool that can be used at point-of-care (POC) and promptly and accurately allow the diagnosis of bacterial disease and b) lack of a prognostic POC test to help triage children in need of intensive assistance. Antibiotic therapy is frequently overprescribed as a result of suspected bacterial infections resulting in development of antibiotic resistance. Conversely, in malaria-endemic areas, antibiotics may also be "underprescribed" and children with bacterial pneumonia sent home without antibiotic therapy, when the clinical pneumonia is mistakenly attributed to a co-existing malaria infection. The investigators previously identified combinations of protein with 96% sensitivity and 86% specificity for detecting bacterial disease in Mozambican children with clinical pneumonia. The investigators' prior work showed that it is possible to identify biosignatures for diagnosis and prognosis using few proteins. Recently, other authors also identified different accurate biosignatures (e.g., IP-10, TRAIL and CRP). In this study, the investigators propose to validate and improve upon previous biosignatures by testing prior combinations and seeking novel combinations of markers in 900 pediatric inpatients aged 2 months to 5 years with clinical pneumonia in The Gambia. The investigators will also use alternative case criteria and seek diagnostic and prognostic combination of markers. This study will be conducted in Basse, rural Gambia, in two hospitals associated with the Medical Research Council Unity The Gambia (MRCG). Approximately 900 pediatric patients with clinical pneumonia aged 2 months to 5 years of age will be enrolled. Patients will undergo standard of care test and will have blood proteins measured th
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 837 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2021-04-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03996967
The ClinicalTrials.gov registry entry for NCT03996967 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 837 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03996967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03996967 about?
NCT03996967 is a clinical study titled "Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia". Clinical pneumonia is a leading cause of pediatric hospitalization. The etiology is generally bacterial or viral. Prompt and optimal treatment of pneumonia is critical to reduce mortality. However, adequate pneumonia management is hampered by: a) the lack of a diagnostic tool that can be used at poi...
What is the current status of trial NCT03996967?
This trial is currently completed. The enrollment target is 837 participants. The study started on 2019-02-11. Estimated completion is 2021-04-10.
Who is sponsoring clinical trial NCT03996967?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.